Quality of life and mental health in real-world patients with resected stage III/IV melanoma receiving adjuvant immunotherapy
2023 · Acta Oncologica · 19 citations
https://doi.org/10.1080/0284186x.2023.2165449
K
Kasper Madsen
Herlev Hospital(DK)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
80
Papers
423
Citations
10
h-index
11
i10-index
Kasper Madsen is an academic researcher from Herlev Hospital. The author has contributed to research in topics: Inflammatory Biomarkers in Disease Prognosis & Pancreatic and Hepatic Oncology Research & Cholangiocarcinoma and Gallbladder Cancer Studies. The author has an h-index of 10, co-authored 68 publications.
ORCID: 0009-0006-7612-3906Papers by this author
worksLong-term clinical outcome of patients with metastatic melanoma and initial stable disease during anti-PD-1 checkpoint inhibitor immunotherapy with pembrolizumab
2025 · British Journal of Cancer · 5 citations
https://doi.org/10.1038/s41416-025-03048-8
Complete metabolic response as early predictor of long-term efficacy after adoptive T cell therapy using tumor-infiltrating lymphocytes
2025 · Journal for ImmunoTherapy of Cancer · 1 citations
https://doi.org/10.1136/jitc-2024-010575
Quality of life and mental health in real-world patients with resected stage III/IV melanoma receiving adjuvant immunotherapy
2023 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.21904458
Figure S5 from Prognostic Value of Pretreatment Plasma C-Reactive Protein in Patients with Early-Stage Breast Cancer
2024 · 0 citations
https://doi.org/10.1158/1055-9965.25729077
Figure S3 from Prognostic Value of Pretreatment Plasma C-Reactive Protein in Patients with Early-Stage Breast Cancer
2024 · 0 citations
https://doi.org/10.1158/1055-9965.25729083
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat